According to the latest report by IMARC Group, titled “Biomaterials Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global biomaterials market size reached US$ 102.8 Billion in 2022. Biomaterials are substances engineered to interact with biological systems for specific medical applications or purposes. These materials, which can be either natural or synthetic, play a critical role in medical implants, tissue engineering, and drug delivery systems. One of the primary characteristics of biomaterials is biocompatibility, meaning they are designed to perform their intended function without eliciting any undesirable local or systemic effects in the host. Another crucial characteristic is the mechanical integrity of the biomaterial, as it often needs to withstand physical stresses, especially in applications like joint replacements or cardiovascular stents. Features of biomaterials often include controllable degradation rates, which is particularly important for temporary implants that dissolve over time. In tissue engineering, biomaterials often serve as scaffolds that guide tissue growth and eventually degrade, leaving only the newly regenerated tissue. Additionally, the surface properties of biomaterials are engineered to control interactions with biological tissues; for example, some materials are designed to encourage cell adhesion while others are meant to resist bacterial colonization. Other features include high tensile strength for durability, porosity for nutrient flow and cell migration, and thermal stability to withstand sterilization processes. Advancements in material science have expanded the range of biomaterials available, incorporating smart materials that can respond to external stimuli like temperature and ph. Furthermore, the integration of nanotechnology has led to the development of biomaterials with highly specialized functionalities, like targeted drug delivery or real-time monitoring of physiological parameters.
Global Biomaterials Market Trends:
The escalating demand for eco-friendly materials and medical implants represent one of the key factors driving the market growth of biomaterials. Moreover, the focus on sustainability and environmental conservation is spurring the adoption of biomaterials. In line with this, it is moving towards greener alternatives, backed by supportive regulatory frameworks, is a major growth inducing factor. In addition to this, increasing health concerns and the need for advanced medical solutions are compelling healthcare industries and consumers to invest in biomaterial-based products which, in turn, is propelling the market growth. Besides this, technological advancements in material science are encouraging the utilization of biomaterials in diverse applications, is driving the market growth. Along with this, innovations in manufacturing techniques and economies of scale are making high-quality biomaterials increasingly cost-effective. This affordability is expanding the user base across multiple sectors, including healthcare, textiles, and environmental remediation, thereby fostering the market growth. Other factors such as the growing awareness about sustainable practices and the increasing focus on quality healthcare, are creating a positive market outlook across the globe. Looking forward, the market value is projected to reach US$ 202.7 Billion by 2028, expanding at a CAGR of 11.43% during 2023-2028.
- On the basis of the type, the market has been divided into natural, metallic, ceramic, and polymeric biomaterials. Currently, metallic biomaterials hold the largest market share.
- Based on the application, the market has been classified into neurology, cardiology, orthopedics, wound care, dental, plastic surgery, and others.
- On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. Currently, North America is dominating the market.
- The competitive landscape of the industry has also been examined, with some of the key players being BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc and Zimmer Biomet.
|Base Year of the Analysis
||Type, Application, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc and Zimmer Biomet.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800